rs79143859

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000092.5(COL4A4):​c.3233C>T​(p.Ala1078Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,613,386 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1078T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.012 ( 25 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 41 hom. )

Consequence

COL4A4
NM_000092.5 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.98

Publications

3 publications found
Variant links:
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]
COL4A4 Gene-Disease associations (from GenCC):
  • autosomal recessive Alport syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Alport syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • hematuria, benign familial, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • autosomal dominant Alport syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035594404).
BP6
Variant 2-227047531-G-A is Benign according to our data. Variant chr2-227047531-G-A is described in ClinVar as Benign. ClinVar VariationId is 334710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0116 (1767/152198) while in subpopulation AFR AF = 0.0406 (1686/41528). AF 95% confidence interval is 0.039. There are 25 homozygotes in GnomAd4. There are 824 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR,AD,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000092.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
NM_000092.5
MANE Select
c.3233C>Tp.Ala1078Val
missense
Exon 35 of 48NP_000083.3P53420

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
ENST00000396625.5
TSL:5 MANE Select
c.3233C>Tp.Ala1078Val
missense
Exon 35 of 48ENSP00000379866.3P53420

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1764
AN:
152080
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0406
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00308
AC:
767
AN:
249032
AF XY:
0.00226
show subpopulations
Gnomad AFR exome
AF:
0.0446
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000796
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00132
AC:
1928
AN:
1461188
Hom.:
41
Cov.:
30
AF XY:
0.00112
AC XY:
814
AN XY:
726940
show subpopulations
African (AFR)
AF:
0.0491
AC:
1641
AN:
33436
American (AMR)
AF:
0.00190
AC:
85
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000243
AC:
27
AN:
1111562
Other (OTH)
AF:
0.00264
AC:
159
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0116
AC:
1767
AN:
152198
Hom.:
25
Cov.:
32
AF XY:
0.0111
AC XY:
824
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0406
AC:
1686
AN:
41528
American (AMR)
AF:
0.00347
AC:
53
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68008
Other (OTH)
AF:
0.00994
AC:
21
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
91
182
273
364
455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00651
Hom.:
26
Bravo
AF:
0.0132
ESP6500AA
AF:
0.0376
AC:
139
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.00379
AC:
458
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Alport syndrome (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Focal segmental glomerulosclerosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.059
T
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.32
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
0.47
N
PhyloP100
2.0
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.030
N
REVEL
Benign
0.24
Sift
Benign
0.61
T
Sift4G
Benign
0.58
T
Polyphen
0.92
P
Vest4
0.26
MVP
0.83
MPC
0.14
ClinPred
0.026
T
GERP RS
5.0
Varity_R
0.071
gMVP
0.25
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79143859; hg19: chr2-227912247; API